Phadia Announces Commercial Availability Of Peanut Allergen Component Tests

Phadia, the allergy and autoimmune disease diagnostics developer, Tuesday announced that the uKnow Peanut Test, its peanut allergen component test, is now commercially available in the United States through the Phadia Immunology Reference Laboratory.

WWJ Newsradio 950–08/16/2011


Phadia Makes More Advances In Personalized Medicine

Phadia, the drug development firm with its headquarters in Uppsala, Sweden and research operations in Kalamazoo County’s Portage, Monday announced new services to help the pharmaceutical industry maximize the safety and effectiveness of its biopharmaceutical drug development investments.


FDA OKs Two More Celiac Assays From Phadia

Portage-based Phadia announced Wednesday that it has received clearance from the United States Food and Drug Administration for two new autoimmune antibody assays. The new assays will provide physicians with additional tools needed to aid […]